Trading status Status de
  • Prices realtime
    • Indizes
      • UC DAX
      • UC MDAX
      • UC TECDAX
      • UC DJI
      • UC ESTOXX
      • UC NASQAD 100
    • Shares
    • ETFs & FUNDS
    • Bonds
    • Crypto
  • Screen markets
    • Stock screener
    • Certifcate Screener
    • ETF Screener
    • Fund Screener
    • Bond screener
  • Trading ideas
    • risk indices
      • risk indices
      • EU Intraday
      • EU Long Term
      • US Intraday
      • US Longterm
    • New on gettex
      • New listings stocks
      • New listings bonds
      • New intraday certificates
    • Blog
    • Newsletter
    • Watchlist
    • Support
  • Trading
    • Trading Calendar
    • Extended trading hours
    • Listing on demand
    • Announcements
    • Quality Reports
    • Delayed Data
    • Regulations
    • Become a Trade Participant
    • Cancellations
  • About Gettex
    • FAQs
    • Press
    • Partners
    • Committees
    • Career
    • Service & Contact
  • Why gettex

News overview

  • «
  • ‹
  • …
  • 5138
  • 5139
  • 5140
  • …
  • ›
  • »

2026-05-28

Omnicell (OMCL) Up 0.1% Since Last Earnings Report: Can It Continue?

2026-05-28

Oneok (OKE) Down 1.2% Since Last Earnings Report: Can It Rebound?

2026-05-28

Why Is Omnicom (OMC) Down 1.8% Since Last Earnings Report?

2026-05-28

Nabors (NBR) Down 6.3% Since Last Earnings Report: Can It Rebound?

2026-05-28

Why Is OGE Energy (OGE) Up 1.8% Since Last Earnings Report?

2026-05-28

Northern Oil and Gas (NOG) Down 23.6% Since Last Earnings Report: Can It Rebound?

2026-05-28

Why Is Markel Group (MKL) Up 5% Since Last Earnings Report?

2026-05-28

Landstar (LSTR) Up 8.9% Since Last Earnings Report: Can It Continue?

2026-05-28

Graco Foundation Marks Company′s Centennial with $1 Million Commitment to Minnesota Nonprofits

2026-05-28

Reliance bets big on AI to reshape content, streaming and viewer engagement

2026-05-28

Reservoir media forecasts fiscal 2027 revenue of $186M-$191M while integrating Viral Wave

2026-05-28

EQS-News: Menarini Group Presents New Data from the Phase 1b/2 ELEVATE Study of Elacestrant in Combination with Capivasertib in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

  • «
  • ‹
  • …
  • 5138
  • 5139
  • 5140
  • …
  • ›
  • »

Preset online depot

Favorites: Zertifikate-Finder FAQs Newsletter
Realtimeprices 10/Aug/2026 15:51:10
Tradingtime Mo-Fr: 7:30-23 h
Certificates 8:00-22 h
  • Imprint
  • Legal notice
  • Data protection
  • Contact
  • Cookies